Pharmaceutical Research Overview
Super Tadapox is a combination pharmaceutical preparation containing tadalafil 40mg and dapoxetine 60mg per unit, manufactured by Dharam Distributors for laboratory research applications. This dual-action compound represents a hybrid approach to studying phosphodiesterase type 5 inhibition alongside selective serotonin reuptake inhibition mechanisms. Research institutions examine this formulation to investigate the pharmacological interactions between these distinct molecular pathways. The preparation offers researchers at Stroid UK Shop access to a standardised combination for comparative studies against individual compound effects.
Mechanism Investigation Applications
Laboratory studies focus on the dual-pathway modulation provided by this combination formulation. Tadalafil functions as a selective phosphodiesterase type 5 inhibitor, while dapoxetine operates through selective serotonin reuptake inhibition. Research protocols examine the pharmacokinetic interactions between these mechanisms in controlled experimental conditions. Academic institutions utilise this preparation to study tissue-specific enzyme inhibition patterns and neurotransmitter modulation effects. Comparative research designs evaluate the compound against individual components available through our erection drugs and dapoxetine category for comprehensive mechanistic analysis.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Components | Tadalafil 40mg, Dapoxetine 60mg |
| Manufacturer | Dharam Distributors |
| Form | Oral preparation |
| CAS Numbers | Tadalafil: 171596-29-5, Dapoxetine: 119356-77-3 |
| Storage Requirements | Room temperature, dry conditions |
| Purity Grade | Pharmaceutical standard |
Researchers interested in related compounds can explore our SARMs collection and peptides range for complementary research applications.
Laboratory Compliance Statement
Super Tadapox is supplied exclusively for in-vitro laboratory research and analytical testing purposes. This compound is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Research institutions must ensure appropriate safety protocols and regulatory compliance when handling this material. All studies should be conducted by qualified personnel with proper analytical equipment and documentation procedures.
